Evidence mapPaperPMID 41009465Full record

ReviewInternational journal of molecular sciences2025

Role of Mast Cells in Human Health and Disease: Controversies and Novel Therapies.

Miguel Ángel Galván-Morales, Juan Carlos Vizuet-de-Rueda, Josaphat Miguel Montero-Vargas, Luis M Teran

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Interactions Between Tryptase-Positive Mast Cells and Melanin-AInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Miguel Ángel Galván-MoralesDepartamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Colonia Sección XVI, Alcaldía Tlalpan, Ciudad de México CP. 14080, Mexico.ORCID 0000-0002-7663-0645
Juan Carlos Vizuet-de-RuedaDepartamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Colonia Sección XVI, Alcaldía Tlalpan, Ciudad de México CP. 14080, Mexico.ORCID 0000-0002-3789-1826
Josaphat Miguel Montero-VargasDepartamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Colonia Sección XVI, Alcaldía Tlalpan, Ciudad de México CP. 14080, Mexico.ORCID 0000-0002-7471-9152
Luis M TeranDepartamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Colonia Sección XVI, Alcaldía Tlalpan, Ciudad de México CP. 14080, Mexico.ORCID 0000-0003-1806-1779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells have been implicated in allergic diseases such as asthma, rhinitis, conjunctivitis, atopic dermatitis, urticaria, and anaphylaxis. However, it is now well established that they also fulfill critical roles in tissue homeostasis, repair, and defense. Despite considerable progress, their ontogeny, proliferation, and differentiation remain subjects of debate, as does their involvement in a wide spectrum of diseases, including cancer and cardiovascular disorders. What remains indisputable is their essential contribution to both innate and adaptive immune responses. Importantly, the activity of their effector molecules can elicit either protective or deleterious outcomes. A complete absence of mast cells (MCs) in humans would undoubtedly provide valuable insight into their fundamental role in immunity, much as neutropenia and agranulocytosis have historically clarified the functions of neutrophils. In this review, we provide a comprehensive overview of mast cell (MC) biology, emphasizing their functional diversity and pathogenic potential. Furthermore, we highlight emerging therapeutic strategies, particularly the use of inhibitors and monoclonal antibodies, which are reshaping current approaches to conditions such as allergy, mastocytosis, and related disorders.

Indexed as

Mast CellsAnimalsHumansHypersensitivityMastocytosisacalabrutiniballergic diseaseC/EBPαc-kitFcεRIα+homeostasisIgEIL-3mast cellsmastocytosismatinibomalizumabremibrutinibtyrosine kinase inhibition

Identifiers

PMID41009465
PMCPMC12469557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.